Article

Many poststroke survivors develop spasticity. Spasticity is usually associated
with other neurologic impairments, in particular paresis, which complicate the
evaluation of its consequences and of treatment outcomes.
The diagnosis and the
assessment of spasticity are based on clinical examination,
in particular
resistance to passive movement and abnormal involuntary muscle contraction.
Nonpharmacologic and pharmacologic treatments are commonly combined to manage
spasticity, based on prespecified goals. There is evidence supporting the
effectiveness and safety of most medications commonly used to treat spasticity ;
however, more evidence is needed regarding functional outcomes and the impact of
combining treatment modalities.
CI - Copyright (c) 2015 Elsevier Inc. All rights reserved.

Langue : ANGLAIS